|
|
Article: UK's NICE issues chronic hand eczema appraisal doc.
- Article from:
- Pharma Marketletter
- Article date:
- May 18, 2009
CopyrightCOPYRIGHT 2009 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The National Institute for Health and Clinical Excellence (NICE), which determines which drugs should be covered by the UK National Health Service outside Scotland, has issued its preliminary recommendation in favor of Swiss drugmaker Basilea Pharmaceutica's Toctino (alitretinoin) for patients with chronic hand eczema. The Institute proposes that the agent be used once-a day for adults with the condition who ...
Related newspaper, magazine, and journal articles:
|
|
Article: Hand eczema
Dermatology Times;
November 1, 2009 ;
700+ words
... ... to-treat cases International report - Severe chronic hand eczema (CHE) has always been difficult to treat. But ... Study A (the BACH study - Benefit of Alitretinoin in Chronic Hand Eczema) was a double-blinded, placebo-controlled trial ...
|
|